These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37081842)

  • 1. Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer.
    Miao S; Ju G; Jiang C; Xue B; Zhao L; Zhang R; Diao H; Yu X; Zhang L; Pan X; Zhang H; Zang L; Wang L; Zhou T
    Front Med (Lausanne); 2023; 10():1167676. PubMed ID: 37081842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA BRAF-regulated lncRNA 1 promotes lymph node invasion, metastasis and proliferation, and predicts poor prognosis in breast cancer.
    Jiang J; Shi SH; Li XJ; Sun L; Ge QD; Li C; Zhang W
    Oncol Lett; 2018 Jun; 15(6):9543-9552. PubMed ID: 29805676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of miRNAs associated with lymph node metastasis in Her-2-positive breast cancer and their relationship with prognosis.
    Qiao EQ; Yang HJ; Zhang XP
    J Zhejiang Univ Sci B; 2020 Jun; 21(6):495-508. PubMed ID: 32478495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DYNLT1 promotes mitochondrial metabolism to fuel breast cancer development by inhibiting ubiquitination degradation of VDAC1.
    Huang L; Wei B; Zhao Y; Gong X; Chen L
    Mol Med; 2023 Jun; 29(1):72. PubMed ID: 37280526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal transfer of miR-15b-3p enhances tumorigenesis and malignant transformation through the DYNLT1/Caspase-3/Caspase-9 signaling pathway in gastric cancer.
    Wei S; Peng L; Yang J; Sang H; Jin D; Li X; Chen M; Zhang W; Dang Y; Zhang G
    J Exp Clin Cancer Res; 2020 Feb; 39(1):32. PubMed ID: 32039741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer.
    Miao S; Ju G; Jiang C; Xue B; Zhao L; Zhang R; Diao H; Yu X; Zhang L; Pan X; Zhang H; Zang L; Wang L; Zhou T
    Front Med (Lausanne); 2024; 11():1375203. PubMed ID: 38375325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the role of FADS family members in breast cancer based on bioinformatic analysis and experimental validation.
    Zhao T; Gao P; Li Y; Tian H; Ma D; Sun N; Chen C; Zhang Y; Qi X
    Front Immunol; 2023; 14():1074242. PubMed ID: 37122728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A six-gene signature related with tumor mutation burden for predicting lymph node metastasis in breast cancer.
    Wang C; Xu K; Deng F; Liu Y; Huang J; Wang R; Guan X
    Transl Cancer Res; 2021 May; 10(5):2229-2246. PubMed ID: 35116541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA circPRMT5 is upregulated in breast cancer and is required for cell proliferation and migration.
    Li X; Zhang D; Feng Z; Xu X; Zhang J; Yu A; Zhu L; Xiao J; Du J; Chen M
    Turk J Med Sci; 2022 Apr; 52(2):303-312. PubMed ID: 36161608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCDHA1 High Expression is Associated With Poor Prognosis and Correlated With Immune Cell Infiltration in Breast Cancer.
    Du J; Wu K
    Clin Breast Cancer; 2023 Jun; 23(4):397-407. PubMed ID: 36858841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial-related genes as prognostic and metastatic markers in breast cancer: insights from comprehensive analysis and clinical models.
    Fang Y; Zhang Q; Guo C; Zheng R; Liu B; Zhang Y; Wu J
    Front Immunol; 2024; 15():1461489. PubMed ID: 39380996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-omics analysis reveals the unique landscape of DLD in the breast cancer tumor microenvironment and its implications for immune-related prognosis.
    Xu L; Yang L; Zhang D; Wu Y; Shan J; Zhu H; Lian Z; He G; Wang C; Wang Q
    Comput Struct Biotechnol J; 2024 Dec; 23():1201-1213. PubMed ID: 38545600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of miR-223 in breast cancer; an integrated analysis.
    Sahin Y; Altan Z; Karabulut A; Saadat KASM; Arslan A
    Mol Biol Rep; 2023 Dec; 50(12):10179-10188. PubMed ID: 37924447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer.
    Fang Z; Song YX; Wo GQ; Zhou HL; Li L; Yang SY; Chen X; Zhang J; Tang JH
    Ann Transl Med; 2022 Dec; 10(23):1280. PubMed ID: 36618780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of a prognostic risk model based on caveolin family genes for breast
    Tang Q; Wang S; Di Z; Li H; Xu K; Hu X; Di M
    Front Cell Dev Biol; 2022; 10():822187. PubMed ID: 36147736
    [No Abstract]   [Full Text] [Related]  

  • 17. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
    Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
    Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trefoil factor 1 (TFF1) is a potential prognostic biomarker with functional significance in breast cancers.
    Yi J; Ren L; Li D; Wu J; Li W; Du G; Wang J
    Biomed Pharmacother; 2020 Apr; 124():109827. PubMed ID: 31986408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial DNA methylation is a predictor of immunotherapy response and prognosis in breast cancer: scRNA-seq and bulk-seq data insights.
    Ma Y; Du J; Chen M; Gao N; Wang S; Mi Z; Wei X; Zhao J
    Front Immunol; 2023; 14():1219652. PubMed ID: 37457713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC01234 promoted malignant behaviors of breast cancer cells via hsa-miR-30c-2-3p/CCT4/mTOR signaling pathway.
    Tang C; Li C; Chen C; Chen T; Zhu J; Sun M; Wang P; Han C
    Taiwan J Obstet Gynecol; 2024 Jan; 63(1):46-56. PubMed ID: 38216268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.